@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-XJS7JBCV-H
  skos:prefLabel "Oligopeptides"@fr, "Oligopeptides"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-BXFVDLTQ-8 .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-XBKVG9ZF-4
  skos:prefLabel "HIV Protease Inhibitors"@en, "Inhibiteurs de protéase du VIH"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-BXFVDLTQ-8
  mesh:allowableQualifier jvr:-HQRFT0C6-B, jvr:-H7K65Q8S-Z, jvr:-M63HSDM7-1, jvr:-D0F21513-5, jvr:-T9HQD7ST-J, jvr:-NFTHND7Q-8, jvr:-R0ZCQ8X6-J, jvr:-THHNVC7V-3, jvr:-W6SQV79N-S, jvr:-WK5F724J-1, jvr:-TJHVZCRZ-0, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4, jvr:-S0CS1X5R-5, jvr:-FWD2BGQ0-9, jvr:-XV06LPML-W, jvr:-G4R176S9-J, jvr:-Q3979798-W, jvr:-G30ZJ446-J, jvr:-BT300B3G-Q, jvr:-R3QWLHRG-V, jvr:-NKM836P1-M, jvr:-CB30NGKB-3, jvr:-NB0XHT3S-N, jvr:-SBNWSM1T-R ;
  skos:hiddenLabel "CGP-75176"@fr, "BMS232632"@en, "BMS232632"@fr, "CGP-75176"@en, "BMS23263205"@fr, "Reyataz"@en, "BMS-232632"@fr, "BMS-232632"@en, "CGP 73547"@en, "CGP75355"@fr, "CGP75355"@en, "3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester"@en, "CGP 75176"@en, "CGP-75136"@en, "CGP-75136"@fr, "CGP 75136"@en, "Atazanavir"@en, "CGP-73547"@fr, "CGP-73547"@en, "CGP75176"@fr, "CGP75176"@en, "CGP 75355"@en, "CGP73547"@fr, "CGP75136"@fr, "CGP75136"@en, "BMS-232632-05"@fr, "BMS-232632-05"@en, "CGP-75355"@fr, "CGP-75355"@en, "BMS 232632"@en ;
  skos:prefLabel "Sulfate d'atazanavir"@fr, "Atazanavir Sulfate"@en ;
  a skos:Concept, mesh:Descriptor ;
  mesh:pharmacologicalAction jvr:-XBKVG9ZF-4 ;
  skos:broader jvr:-P551XG36-F, jvr:-XJS7JBCV-H ;
  skos:altLabel "QZU4H47A3S"@fr, "QZU4H47A3S"@en, "229975-97-7"@fr, "229975-97-7"@en, "4MT4VIE29P"@en, "4MT4VIE29P"@fr ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D000069446> ;
  skos:definition "An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS."@en ;
  dc:created "2015-07-09"^^xsd:date ;
  skos:inScheme jvr: ;
  dc:established "2016-01-01"^^xsd:date ;
  dc:modified "2016-07-11"^^xsd:date .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-P551XG36-F
  skos:prefLabel "Pyridines"@fr, "Pyridines"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-BXFVDLTQ-8 .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .